News & Analysis as of

Life Sciences Venture Capital Emerging Technology Companies

Fenwick & West LLP

Silicon Valley Venture Capital Survey – Fourth Quarter 2023

Fenwick & West LLP on

Our survey analyzed the terms of 171 venture financings closed in the fourth quarter of 2023 by companies headquartered in Silicon Valley. Fourth-quarter Bay Area venture capital financings remained largely flat from the...more

Fenwick & West LLP

Silicon Valley Venture Capital Survey – Third Quarter 2023

Fenwick & West LLP on

Third-quarter Bay Area venture capital financings reached the highest number in the past 12 months (188), including the most Series A financings (100) since Q2 2021. However, Q3 was notably consistent with the prior quarter,...more

Fenwick & West Life Sciences Group

New Funding Cycle for Digital Health Begins on Cautious Note

For digital health startups, the first two months of this year were a welcome departure from 2022, when high inflation and other economic challenges caused investors to press on the brakes and proceed with caution....more

Orrick, Herrington & Sutcliffe LLP

Deal Flow 3.0: European Venture Capital Deal Term Review 2022

Foreword - Despite a shift to economic headwinds, investors injected more than $95B into the European tech market in 2022, the second-largest amount ever. To see how deal terms changed, Orrick developed new technologies and...more

Hogan Lovells

JPM2023 Trendspotting: driving growth through collaboration

Hogan Lovells on

As the industry readies itself for the January 2023 pilgrimage to the J.P. Morgan Healthcare Conference (JPM) and Biotech Showcase in San Francisco, our market-leading life sciences and health care industry team has prepared...more

Hogan Lovells

JPM2023 Trendspotting: funding and early valuation

Hogan Lovells on

As the industry readies itself for the January 2023 pilgrimage to the J.P. Morgan Healthcare Conference (JPM) and Biotech Showcase in San Francisco, our market-leading life sciences and health care industry team has prepared...more

Fenwick & West Life Sciences Group

Digital Health Has Strong Fundamentals to Pull Through Downturn

Digital health has been a powerhouse investment sector since it emerged more than a decade ago. Year-after-year, startups consistently demonstrate their innovations bring real-world benefits and our healthcare system...more

Fenwick & West LLP

Silicon Valley Venture Capital Survey – Second Quarter 2022

Fenwick & West LLP on

Our survey analyzed the terms of 194 venture financings closed in the second quarter of 2022 by companies headquartered in Silicon Valley. While the number of venture financings were down in the second quarter compared to...more

Fenwick & West Life Sciences Group

Economic Conditions Changing, but Digital Health Still Strong

The digital health sector emerged as a juggernaut during the COVID-19 pandemic, with almost $15 billion invested in privately-held digital health companies in 2020 and nearly $30 billion invested last year, according to our...more

Fenwick & West LLP

Silicon Valley Venture Capital Survey – Third Quarter 2021

Fenwick & West LLP on

Our survey analyzed the terms of 260 venture financings closed in the third quarter of 2021 by companies headquartered in Silicon Valley. Key Findings: • Valuation results remain near historical highs with the average...more

Fenwick & West LLP

Silicon Valley Venture Capital Survey – First Quarter 2021

Fenwick & West LLP on

Our latest survey, analyzing the terms of 259 venture financings closed in the first quarter of 2021 by companies headquartered in Silicon Valley, shows valuation results continued their momentum from the fourth quarter of...more

Fenwick & West Life Sciences Group

Rock Health Summit 2020 Takeaways: Digital Health Is Firing on All Cylinders

When investors survey the digital health sector today, they see nearly every number trending upward. There is more deal volume than VCs have seen in past years, with the third quarter of 2020 outpacing anything they’ve...more

Fenwick & West Life Sciences Group

Digital Health Investors Offer Cautious Optimism at Rock Health H1 2020 Event

Venture investors are pleased to see digital health companies continue to transform the healthcare system despite unprecedented challenges brought by the COVID-19 pandemic....more

Fenwick & West Life Sciences Group

Digital Health Investments See Significant Uptick in Q1; Investors Consider COVID-19 Impacts in Coming Months

Despite the changes and uncertainty rippling across the entire venture-backed startup ecosystem, the digital health sector saw its best first quarter since analysts began tracking its performance more than a decade ago,...more

Hutchison PLLC

Hutchison Helps Investors Generate Deal Flow Video

Hutchison PLLC on

Hear how by sitting at the intersection of the law and capital Hutchison PLLC can help connect technology and life sciences entrepreneurs with venture capital....more

Fenwick & West LLP

Silicon Valley Venture Capital Survey - Fourth Quarter 2019 - First Look

Fenwick & West LLP on

We analyzed the terms of 188 venture financings closed in the fourth quarter of 2019 by companies headquartered in Silicon Valley. The quarter recorded the highest average and median price increases in the 16-year history of...more

Fenwick & West LLP

Fenwick’s Top 10: Our Most Popular Articles of 2019

Fenwick & West LLP on

In 2019, we published analysis to help tech and life sciences companies navigate U.S. tax law changes, an evolving IP landscape and new privacy regulations such as the California Consumer Privacy Act. We also tracked venture...more

Fenwick & West Life Sciences Group

Key Takeaways from Fenwick’s 2019 Digital Health Investor Summit

Fenwick’s eighth annual Digital Health Investor Summit took place against the backdrop of strong and increasingly diverse investment markets, a focus on clinical validation of digital health tools, and a healthcare system...more

Fenwick & West LLP

Silicon Valley Venture Capital Survey – Third Quarter 2019 - First Look

Fenwick & West LLP on

We analyzed the terms of 189 venture financings closed in the third quarter of 2019 by companies headquartered in Silicon Valley. The quarter recorded the highest average price increase since mid-2015. The software and...more

Wilson Sonsini Goodrich & Rosati

The Life Sciences Report - Winter/Spring 2019

Venture Fundraising and Investment in Healthcare - U.S. healthcare venture fundraising reached a record $9.6 billion in 2018, continuing a four-year upward trend. This was driven by excellent returns in the sector,...more

Fenwick & West LLP

Silicon Valley Venture Capital Survey – First Quarter 2018

Fenwick & West LLP on

Background – We analyzed the terms of 200 venture financings closed in the first quarter of 2018 by companies headquartered in Silicon Valley. Overview of Fenwick & West Results – Valuation results were generally...more

Morrison & Foerster LLP - JOBS Act

BIO Publishes Study on Capital Raising for Emerging Therapeutic Companies

On May 24, 2016, the Biotechnology Innovation Organization (BIO) published a study, “Emerging Therapeutic Company Investment and Deal Trends,” which collects ten years of data to identify trends affecting “emerging...more

Fenwick & West LLP

Silicon Valley Venture Capital Survey - First Quarter 2016

Fenwick & West LLP on

Background - We analyzed the terms of 148 venture financings closed in the first quarter of 2016 by companies headquartered in Silicon Valley. Overview of Results - The weakening in valuations that began in...more

Foley Hoag LLP

Quarterly Review of Seed, Series A and Series B/Later Round Financings: First Quarter 2015

Foley Hoag LLP on

The Numbers - Venture financing activity in New England decreased modestly in the first quarter of 2015 (-12%) with Seed and B/ Later round activity each decreasing by roughly 20% over Q4 2014. Despite this overall...more

McGuireWoods LLP

Venture Capital Coast to Coast – June 2015

McGuireWoods LLP on

As we reported in January 2015, 2014 was a banner year for venture capital on all fronts, from fundraising, to investment and exits – save, however, for the small drop in the number of deals versus the largest aggregate...more

25 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide